Learn more about whether Haemonetics Corporation or UFP Technologies, Inc. is a better investment based on AAII's A+ Investor ...

In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares closed yesterday at $75.05. Discover outperforming ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to share on Reddit (Opens in new window) Shopping for top-grade THC vape carts in the most popular ...

If you’re on the fence about investing in Haemonetics Corporation or Glaukos Corporation ... and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related ...

(RTTNews) - Haemonetics Corporation (HAE), a provider in medical technology focused on advancing patient outcomes, Tuesday announced that it has finalized the sale of its whole blood assets to GVS ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...

Haemonetics (NYSE:HAE) announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A. The sale has a total cash consideration of up to $67.8 million ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...